Cross-Country Differences in Pain Medication Before and After Spinal Cord Stimulation: A Pooled Analysis of Individual Patient Data From Two Prospective Studies in the United Kingdom and Belgium.
Lisa GoudmanRui V DuarteAnn De SmedtSue CopleySam S EldabeMaartens MoensPublished in: Neuromodulation : journal of the International Neuromodulation Society (2021)
Our combined analysis revealed differences in prescription practice in patients scheduled for SCS implantation between Belgium and United Kingdom. NSAIDs and neuropathic mood agents are more frequently used in the United Kingdom, presumably due to easier access to repeat prescriptions and over the counter medications. After three months of SCS, a decrease in medication use is observed in both countries, with higher reductions in Belgium, presumably due to strict regulations concerning reimbursement criteria.
Keyphrases
- spinal cord
- end stage renal disease
- healthcare
- newly diagnosed
- ejection fraction
- neuropathic pain
- chronic kidney disease
- primary care
- chronic pain
- prognostic factors
- bipolar disorder
- peritoneal dialysis
- electronic health record
- pain management
- machine learning
- big data
- case report
- physical activity
- quality improvement
- sleep quality
- deep learning
- adverse drug